Show simple item record

dc.contributor.advisorShayanfar, Ali
dc.contributor.advisorSarbakhsh, Parvin
dc.contributor.advisorFarnood, Farahnoosh
dc.contributor.authorArshadi Benekohal, Zahra
dc.date.accessioned2020-10-03T09:09:35Z
dc.date.available2020-10-03T09:09:35Z
dc.date.issued2020en_US
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/62659
dc.description.abstractIntroduction: Vitamin B12 or cobalamin is An essential and important vitamin. This vitamin is essential for cell proliferation (hematopoiesis), the health and maintenance of tissues and the strengthening and improvement of immune and nervous system function. Therefore, prevention of vitamin B12 deficiency is important. Supplemental forms of this vitamin that are used to treat vitamin B12 deficiency include cyanocobalamin, hydroxycobalamin, and methylcobalamin. Hemodialysis patients are advised to take oral supplements of this vitamin due to dietary restrictions and anorexia. Among these oral supplements used in hemodialysis Nephrovitis and Nephrotonic tablets contain adjusted amounts of vitamins and minerals required in dialysis patients. The vitamin B12 form in these supplements is cyanocobalamin. Objective: Evaluating the effects of cyanide and thiocyanate retention in chronic hemodialysis patients treated with vitamin B12 supplementation of cyanocobalamin form. Method: This study was a cross-sectional study that after applying the inclusion and exclusion criteria, 30 hemodialysis patients receiving cyanocobalamin supplement and 30 hemodialysis patients without cyanocobalamin supplementation entered the study. Blood samples were taken from these patients and cyanide and thiocyanate concentrations were measured. Colorimetric methods was used to measure cyanide and thiocyanate. The concentrations and the side effects related to these compounds in the both groups were investigated. Results: Obtained data showed that there was no significant difference (p>0.05) between the cyanide and thiocyanate patients concentration receiving cyanocobalamin B12 supplement in two groups during the study period (at least 3 months). Moreover, there were no complications related to cyanide / thiocyanate accumulation in patients and no side effects were observed. Conclusion: In chronic hemodialysis patients, taking vitamin B12 oral supplements of cyanocobalamin type was not associated with cyanide/ thiocyanate-related side effects.en_US
dc.language.isofaen_US
dc.publisherTabriz University of Medical Sciences, Faculty of Pharmacyen_US
dc.relation.isversionofhttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/62658en_US
dc.subjectHemodialysisen_US
dc.subjectVitamin B12en_US
dc.subjectCyanideen_US
dc.subjectThiocyanateen_US
dc.titleMeasurement of cyanide levels in chronic hemodialysis patients treated with vitamin B12 supplementation with cyanocobalamin salineen_US
dc.typeThesisen_US
dc.contributor.supervisorGharekhani, Afshin
dc.contributor.supervisorNoshad, Hamid
dc.identifier.callno4125en_US
dc.description.disciplinepharmacyen_US
dc.description.degreePharm Den_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record